The renin-angiotensin-aldosterone system in adolescent offspring born prematurely to mothers with preeclampsia

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 16, Issue 3, 2015, Pages 529-538

  Washburn, Lisa K ^a   Brosnihan, K Bridget ^a   Chappell, Mark C ^a   Diz, Debra I ^a   Gwathmey, Tanya M ^a   Nixon, Patricia A ^a   Russell, Gregory B ^a   Snively, Beverly M ^a   O'Shea, T Michael ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

fetal programming; prematurity; preterm birth; sex differences; Very low birth weight

Indexed keywords

ALDOSTERONE; STEROID;

ADOLESCENT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREECLAMPSIA; PREMATURITY; PRENATAL CARE; PROGENY; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; VERY LOW BIRTH WEIGHT; BLOOD; MOTHER; MULTIVARIATE ANALYSIS; NEWBORN; PREGNANCY;

ADOLESCENT; ALDOSTERONE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; MOTHERS; MULTIVARIATE ANALYSIS; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; RENIN-ANGIOTENSIN SYSTEM;

EID: 84950321934     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320314526940     Document Type: Article

References (52)

1. Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335: 974.
2. Kajantie E, Eriksson JG, Osmond C, et al. Pre-eclampsia is associated with increased risk of stroke in the adult offspring. Stroke 2009; 40: 1176-1180.
3. Davis EF, Lazdam M, Lewandowski AJ, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 2012; 129: e1552-e1561.
4. Kumar D, Feltham LA, Gornall AG,. Aldosterone excretion and tissue electrolytes in normal pregnancy and pre-eclampsia. Lancet 1959; 1: 541-545.
5. AbdAlla S, Lother H, el Massiery A, et al. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001; 7: 1003-1009.
6. Anton L, Merrill DC, Neves LAA, et al. Activation of local chorionic villi angiotensin II levels but not angiotensin-(1-7) in preeclampsia. Hypertension 2008; 51: 1066-1072.
7. Merrill DC, Karoly M, Chen K, et al. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002; 18: 239-245.
8. Herse F, Staff AC, Hering L, et al. AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J Mol Med (Berl) 2008; 86: 697-703.
9. Hladunewich MA, Kingdom J, Odutayo A, et al. Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J Clin Endocrinol Metab 2011; 96: 3517-3524.
10. Lanz B, Kadereit B, Ernst S, et al. Angiotensin II regulates 11beta-hydroxysteroid dehydrogenase type 2 via AT2 receptors. Kidney Int 2003; 64: 970-977.
11. McCalla CO, Nacharaju VL, Muneyyirci-Delale O, et al. Placental 11β-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies. Steroids 1998; 63: 511-515.
12. Moritz KM, Johnson K, Douglas-Denton R, et al. Maternal glucocorticoid treatment programs alterations in the renin-angiotensin system of the ovine fetal kidney. Endocrinology 2002; 143: 4455-4463.
13. Shaltout HA, Figueroa JP, Rose JC, et al. Alterations in circulatory and renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 in fetal programmed hypertension. Hypertension 2009; 53: 404-408.
14. Phillips JK, Janowiak M, Badger GJ, et al. Evidence for distinct preterm and term phenotypes of preeclampsia. J Matern Fetal Neonatal Med 2010; 23: 622-626.
15. Lazdam M, de la, Horra A, Diesch J, et al. Unique Blood Pressure Characteristics in Mother and Offspring After Early Onset Preeclampsia / Novelty and Significance. Hypertension 2012; 60: 1338-1345.
16. Blair JD, Yuen RKC, Lim BK, et al. Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. Mol Hum Reprod 2013; 19: 697-708.
17. Hogg K, Blair JD, McFadden DE, et al. Early onset pre-eclampsia is associated with altered DNA methylation of cortisol-signalling and steroidogenic genes in the placenta. PLoS One 2013; 8: e62969.
18. Ojeda NB, Royals TP, Alexander BT,. Sex differences in the enhanced responsiveness to acute angiotensin II in growth-restricted rats: role of fasudil, a Rho kinase inhibitor. Am J Physiol Renal Physiol 2013; 304: F900-F907.
19. Oken E, Kleinman KP, Rich-Edwards J, et al. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003; 3: 6.
20. Taylor, Whincup, Hindmarsh, et al. Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinatal Epidemiol 2001; 15: 88-94.
21. Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the national high blood pressure education program. national high blood pressure education program working group on hypertension control in children and adolescents. Pediatrics 1996; 98: 649-658.
22. Nakamoto H, Ferrario CM, Fuller SB, et al. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension 1995; 25: 796-802.
23. Helsel DR,. Nondetects and data analysis: statistics for censored environmental data. Hoboken, NJ: John Wiley and Sons, 2005, p. 162.
24. Vasan RS, Evans JC, Larson MG, et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004; 351: 33-41.
25. Morley R, Kennedy K, Lucas A, et al. Mode of delivery and childhood blood pressure. Pediatr Res 2000; 47: 463-467.
26. Tetlow HJ, Broughton PF,. Studies on the effect of mode of delivery on the renin-angiotensin system in mother and fetus at term. Br J Obstet Gynaecol 1983; 90: 220-226.
27. Gennari-Moser C, Khankin EV, Schuller S, et al. Regulation of placental growth by aldosterone and cortisol. Endocrinology 2011; 152: 263-271.
28. Gennari-Moser C, Khankin EV, Escher GV, et al. Vascular endothelial growth factor-a and aldosterone: relevance to normal pregnancy and preeclampsia. Hypertension 2013; 61: 1111-1117.
29. Salas SP, Rosso P, Espinoza R, et al. Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol 1993; 81: 1029-1033.
30. Franco MC, Casarini DE, Carneiro-Ramos MS, et al. Circulating renin angiotensin system and catecholamines in childhood: is there a role for birth weight? Clin Sci (Lond) 2007; 114: 375-80.
31. Martinez-Aguayo A, Aglony M, Bancalari R, et al. Birth weight is inversely associated with blood pressure and serum aldosterone and cortisol levels in children. Clin Endocrinol 2012; 76: 713-718.
32. Washburn L, Nixon P, Russell G, et al. Adiposity in adolescent offspring born prematurely to mothers with preeclampsia. J Pediatr 2013; 162: 912-917.
33. Tuck ML, Sowers J, Dornfeld L, et al. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304: 930-933.
34. Massiera F, Bloch-Faure M, Ceiler D, et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001; 15: 2727-2729.
35. Engeli S, Bohnke J, Gorzelniak K, et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45: 356-362.
36. Rondinone CM, Rodbard D, Baker ME,. Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology 1993; 132: 2421-2426.
37. Stark MJ, Clifton VL, Wright IM,. Neonates born to mothers with preeclampsia exhibit sex-specific alterations in microvascular function. Pediatr Res 2009; 65: 292-295.
38. Ojeda NB, Grigore D, Yanes LL, et al. Testosterone contributes to marked elevations in mean arterial pressure in adult male intrauterine growth restricted offspring. Am J Physiol Regul Integr Comp Physiol 2007; 292: R758-R763.
39. Ojeda NB, Grigore D, Robertson EB, et al. Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring. Hypertension 2007; 50: 679-685.
40. Lu F, Bytautiene E, Tamayo E, et al. Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol 2007; 197: 418-425.
41. Cnattingius S, Reilly M, Pawitan Y, et al. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A 2004; 130: 365-371.
42. Escher G, Cristiano M, Causevic M, et al. High aldosterone-to-renin variants of CYP11B2 and pregnancy outcome. Nephrol Dial Transplant 2009; 24: 1870-1875.
43. Doridot L, Houry De, Gaillard H, et al. miR-34a expression, epigenetic regulation, and function in human placental diseases. Epigenetics 2014; 9: PMID: 24081307; http://dx.doi.org/10.4161/epi.26196.
44. Burdge GC, Lillycrop KA,. Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Annu Rev Nutr 2010; 30: 315-339.
45. Kerstens MN, Kobold ACM, Volmer M, et al. Reference values for aldosterone-renin ratios in normotensive individuals and effect of changes in dietary sodium consumption. Clin Chem 2011; 57: 1607-1611.
46. Martinez-Aguayo A, Aglony M, Campino C, et al. Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. Hypertension 2010; 56: 391-396.
47. Simoes E, Silva AC, Diniz JS, Regueira FA, et al. The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension. J Pediatr 2004; 145: 93-98.
48. Ferrario CM, Martell N, Yunis C, et al. Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. Am J Hypertens 1998; 11: 137-146.
49. Yamamoto T, Nakagawa T, Suzuki H, et al. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 2007; 18: 1558-1565.
50. Xiao F, Hiremath S, Knoll G, et al. Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes. PLoS One 2012; 7: e37649.
51. Cohen JA, Lindsey SH, Pirro NT, et al. Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain. Am J Physiol Renal Physiol 2010; 299: F35-F42.
52. Hochner H, Friedlander Y, Calderon-Margalit R, et al. Associations of maternal prepregnancy body mass index and gestational weight gain with adult offspring cardiometabolic risk factors: the jerusalem perinatal family follow-up study. Circulation 2012; 125: 1381-1389.